Full-Time

Executive IT Service Representative

Deadline 8/4/25
Bristol Myers Squibb

Bristol Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

Compensation Overview

$115.5k - $140k/yr

+ Incentive Cash + Stock Opportunities

Company Historically Provides H1B Sponsorship

Princeton, NJ, USA

In Person

Category
🔒IT & Security (2)
,
Required Skills
ServiceNow
iOS/Swift
Customer Service
Android Development
Requirements
  • In depth knowledge of Windows, MacOS, iOS and Android Operating Systems
  • Thorough understanding of collaboration tools and platforms, with an emphasis on Microsoft Teams, but including Zoom and Webex.
  • Microsoft O365 suite of applications including cloud based and mobile versions as well as use of CoPilot
  • Working knowledge of ServiceNow
  • Home networking and wireless troubleshooting and configuration
  • General knowledge of Audio/Video and clear understanding of how it is used in a meeting environment
  • Demonstrate sound business and customer service knowledge, ability to learn quickly and build relationships to effectively support the business
  • Exceptional customer service skills and a demonstrated record of customer focus
  • Excellent interpersonal skills with ability to explain technical details to those that are technical or nontechnical
  • Possess the highest standards of ethics, integrity, compliance and financial stewardship
  • Highly effective written and oral communications skills
  • Demonstrate technical resourcefulness and ability to make timely decisions
  • Ability to deescalate and handle stress and pressure
  • Must have exceptional analytical, problem-solving, troubleshooting, and technical skills.
  • Extreme level of discretion in handling confidential information; with a clear understanding of responsibility and compliance related to elevated system access
  • Candidate should be action and closure oriented; results driven, with the skill to define and implement solutions
  • Capable of working independently and effectively managing competing priorities
  • Strong team collaboration is a must, but also self-motivated and ingenious when addressing challenges.
Responsibilities
  • A member of the Executive Service Team responsible for the coordinated delivery of 24/7 IT services which include the technical support and guidance to our senior most leaders.
  • This is a client facing role with a need to be physically available on site as well as a willingness to travel when necessary
  • Primary back-up to support C-Suite
  • Main point of contact for senior leaders for end-to-end accountability of all IT related matters
  • As a technologist and SME, provide technical consulting services and mentoring for Executives and their assistants on present and future digital capabilities and device nuances
  • Where appropriate, manage and coordinate the update of all executive technology, ensuring consistency, security, and resiliency of personal computing devices with sensitivity to scheduling needs
  • Primary liaison between IT and senior leadership to ensure clear understanding of company digital capabilities and awareness of key IT strategies and initiatives.
  • Provide support and insight at off-site venues for the planning, management and execution of events/meetings personally or partnering with on-site staff when available to include board level support when needed
  • Make technical recommendations aligned with company standards, capabilities and broader IT strategy based on client need and productivity goals.

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs that are affordable alternatives to their innovative medicines, ensuring they meet high safety and quality standards. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, along with a strong commitment to sustainability and corporate responsibility. The company's goal is to improve patient outcomes by providing effective and affordable healthcare solutions while adhering to Environmental, Social, and Governance (ESG) principles.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • Chris Shibutani's appointment may drive strategic growth and innovation at BMS.
  • Advancements in targeted protein degradation enhance therapeutic offerings in oncology.
  • Partnership with BioNTech could provide a competitive edge against Merck's Keytruda.

What critics are saying

  • Antitrust litigation over Pomalyst could impact BMS's market position in oncology.
  • Reliance on real-world data presents challenges in data quality and implementation.
  • High costs and technical challenges in space research could affect treatment feasibility.

What makes Bristol Myers Squibb unique

  • BMS collaborates with BioNTech for next-gen cancer immunotherapy, enhancing oncology portfolio.
  • Focus on real-world data strategies could lead to faster drug market entry.
  • Developing bone disease treatments in space positions BMS as a leader in innovative research.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Company News

ISS National Lab
Jul 7th, 2025
This is Not the Time to Cut Space-enabled Medical Research

Bristol-Myers Squibb is developing novel bone disease treatments in space, and the National Stem Cell Foundation is studying 3D brain organoids derived from patients with Parkinson's disease in microgravity to observe disease progression more rapidly with the aim of identifying potential biomarkers for early diagnosis and therapeutic targets.

The Pharma Letter
Jun 26th, 2025
Bristol Myers faces new antitrust suit over multiple myeloma drug Pomalyst

Bristol Myers faces new antitrust suit over multiple myeloma drug Pomalyst.

Unlearn
Jun 24th, 2025
The Best 15 Minutes You'll Spend on Clinical Trials Today

At the 2025 "Digital Breakthrough for Pharma" Summit hosted by Bristol Myers Squibb, Unlearn's co-founder and machine learning scientist, Aaron Smith, took the stage to explain exactly how that vision is now a reality.

ROI-NJ
Jun 13th, 2025
Bristol Myers Squibb Names Shibutani As Evp, Chief Strategy Officer

Bristol Myers Squibb (BMS) this week appointed Chris Shibutani as executive vice president, chief strategy officer, effective immediately. Shibutani’s role is a new position on the BMS leadership team. The announcement was made on a LinkedIn post.Shibutani will lead the development and advancement of the company’s long-term strategic plan, collaborating across the enterprise to drive innovation and growth. He brings more than 25 years of experience in the financial services industry covering global pharmaceutical, biotechnology and medical device industries.Prior to BMS, Shibutani served as managing director in the global investment research division at Goldman Sachs. Previous roles include senior analyst positions at Hambrecht & Quist, Cowen, UBS, and J.P. Morgan.Before his career in finance, Shibutani was a physician trained in anesthesiology and critical care medicine at Massachusetts General Hospital and practiced at Memorial Sloan Kettering Cancer Center

PharmaData
Jun 13th, 2025
Bristol Myers Squibb Highlights Targeted Protein Degradation Data, Including CELMoD Agents, at EHA 2025

Bristol Myers Squibb highlights targeted protein degradation advances, including CELMoD agents and BCL6 Ligand-Directed Degrader, at EHA 2025 in Milan, Italy.